NCT01492959View on ClinicalTrials.gov

Observational Study With InnoLet® in Daily Clinical Practice

CompletedOBSERVATIONAL
Enrollment

1,030

Participants

Timeline

Start Date

March 23, 2004

Primary Completion Date

March 23, 2005

Study Completion Date

March 23, 2005

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin human

Insulin human delivered with the InnoLet® device was prescribed according to product labelling to subjects in need of insulin treatment

Trial Locations (1)

137-920

Novo Nordisk Investigational Site, Seoul

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY